Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Fujiwara

Showing results (131-140 of 497) with videos related to

Pageof 50
Sort By:
World Journal of Gastroenterology|June 20, 2014
Role of the Na ⁺/K ⁺/2Cl⁻ cotransporter NKCC1 in cell cycle progression in human esophageal squamous cell carcinomaAtsushi Shiozaki, Yoshito Nako, Daisuke Ichikawa, et al.
American Journal of Cancer Research|January 8, 2024
Pancreatic fistula as a pivotal prognostic factor among postoperative complications in gastric cancerRyo Ishida, Shuhei Komatsu, Yusuke Takashima, et al.
Japanese Journal of Clinical Oncology|October 18, 2006
The range of tumor extension should have precedence over the location of the deepest tumor center in determining the regional lymph node grouping for widely extending esophageal carcinomasYuji Ueda, Atsushi Shiozaki, Hirosumi Itoi, et al.
The British Journal of Surgery|July 10, 2024
Minimally Invasive transCervical oEsophagectomy (MICE) for oesophageal cancer: prospective cohort study (IDEAL stage 2A)Richard J M T Vercoulen, Linde van Veenendaal, Irene F Kramer, et al.
Journal of the Anus, Rectum and Colon|May 1, 2024
Does Neoadjuvant Chemoradiotherapy Have an Additional Effect to Lateral Pelvic Lymph Node Dissection for Rectal Cancer?Kazuya Takabatake, Hiroki Shimizu, Yoshiaki Kuriu, et al.
Immunotherapy|February 25, 2017
Reprogrammed chondrocytes engineered to produce IL-12 provide novel ex vivo immune-gene therapy for cancerHiroyuki Tada, Tsunao Kishida, Hitoshi Fujiwara, et al.
Anticancer Research|February 9, 2013
Anti-phosphohistone H3 as an independent prognostic factor in human esophageal squamous cell carcinomaShingo Nakashima, Atsushi Shiozaki, Daisuke Ichikawa, et al.
Anticancer Research|November 29, 2005
Possible inhibition of cancer cell adhesion to the extracellular matrix in NK4-induced suppression of peritoneal implantationMamoru Yoshimura, Hitoshi Fujiwara, Takeshi Kubota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 2005
[Multiple hepatocellular carcinomas successfully treated by combined therapies]Toshiya Ochiai, Teruhisa Sonoyama, Shojiro Kikuchi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 17, 2017
Overexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinomaTsutomu Kawaguchi, Shuhei Komatsu, Daisuke Ichikawa, et al.
Pageof 50

Showing results (131-140 of 497) with videos related to

Sort By:
Pageof 50
World Journal of Gastroenterology|June 20, 2014
Role of the Na ⁺/K ⁺/2Cl⁻ cotransporter NKCC1 in cell cycle progression in human esophageal squamous cell carcinomaAtsushi Shiozaki, Yoshito Nako, Daisuke Ichikawa, et al.
American Journal of Cancer Research|January 8, 2024
Pancreatic fistula as a pivotal prognostic factor among postoperative complications in gastric cancerRyo Ishida, Shuhei Komatsu, Yusuke Takashima, et al.
Japanese Journal of Clinical Oncology|October 18, 2006
The range of tumor extension should have precedence over the location of the deepest tumor center in determining the regional lymph node grouping for widely extending esophageal carcinomasYuji Ueda, Atsushi Shiozaki, Hirosumi Itoi, et al.
The British Journal of Surgery|July 10, 2024
Minimally Invasive transCervical oEsophagectomy (MICE) for oesophageal cancer: prospective cohort study (IDEAL stage 2A)Richard J M T Vercoulen, Linde van Veenendaal, Irene F Kramer, et al.
Journal of the Anus, Rectum and Colon|May 1, 2024
Does Neoadjuvant Chemoradiotherapy Have an Additional Effect to Lateral Pelvic Lymph Node Dissection for Rectal Cancer?Kazuya Takabatake, Hiroki Shimizu, Yoshiaki Kuriu, et al.
Immunotherapy|February 25, 2017
Reprogrammed chondrocytes engineered to produce IL-12 provide novel ex vivo immune-gene therapy for cancerHiroyuki Tada, Tsunao Kishida, Hitoshi Fujiwara, et al.
Anticancer Research|February 9, 2013
Anti-phosphohistone H3 as an independent prognostic factor in human esophageal squamous cell carcinomaShingo Nakashima, Atsushi Shiozaki, Daisuke Ichikawa, et al.
Anticancer Research|November 29, 2005
Possible inhibition of cancer cell adhesion to the extracellular matrix in NK4-induced suppression of peritoneal implantationMamoru Yoshimura, Hitoshi Fujiwara, Takeshi Kubota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 2005
[Multiple hepatocellular carcinomas successfully treated by combined therapies]Toshiya Ochiai, Teruhisa Sonoyama, Shojiro Kikuchi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 17, 2017
Overexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinomaTsutomu Kawaguchi, Shuhei Komatsu, Daisuke Ichikawa, et al.
Pageof 50